OLUKOTUN ADEOYE Y
SEC CIK 1242615 · EDGAR
BoughtSold
Most active insiders at ARWR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Anzalone Christopher Richard | CEO, Dir | — | $24.01M |
| 2 | Hamilton James C | Chief Medical Off | — | $4.63M |
| 3 | O'Brien Patrick | COO | — | $3.12M |
| 4 | PERRY MICHAEL S | Dir | — | $2.00M |
| 5 | Ferrari Mauro | Dir | — | $1.02M |
| 6 | Apel Daniel Joseph | CFO | — | $934.3K |
| 7 | OLUKOTUN ADEOYE Y | Dir | — | $850.5K |
| 8 | Vakiener Victoria | Dir | — | $679.5K |
| 9 | Waddill William D. | Dir | — | $566.0K |
| 10 | Lu Hongbo | Dir | — | $228.3K |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 17:25 | 2026-08-18 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | S - Sale | $86.96 | -2,000 | 31.6K | -6% | -$173.9K | |
| M | 2025-12-23 | 2025-12-19 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | S - Sale | $67.66 | -10.0K | 33.6K | -23% | -$676.6K |
| 2025-12-18 | 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | A - Grant | $0.00 | +7,819 | 43.6K | +22% | $0 | |
| 2025-02-28 | 2024-06-10 | TNXP | Tonix Pharmaceuticals Holding Corp. | OLUKOTUN ADEOYE Y | Dir | J - Other | $1.91 | -0.81 | 0 | -100% | -$1.55 | |
| 2025-01-27 | 2025-01-23 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | S - Sale | $21.00 | -959 | 35.8K | -3% | -$20.1K | |
| 2024-12-30 | 2024-12-27 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | S - Sale | $20.00 | -2,850 | 36.7K | -7% | -$57.0K | |
| 2024-12-20 | 2024-12-18 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | A - Grant | $22.99 | +16.7K | 39.6K | +73% | +$384.7K | |
| 2023-12-19 | 2023-12-15 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | A - Grant | $25.41 | +15.0K | 22.9K | +191% | +$380.8K | |
| 2023-03-06 | 2023-03-03 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | S - Sale | $32.65 | -11.3K | 7,867 | -59% | -$370.6K | |
| D | 2023-01-11 | 2023-01-10 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | A - Grant | $0.00 | +7,867 | 19.2K | +69% | $0 |
| 2022-01-07 | 2022-01-07 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | A - Grant | $0.00 | +6,400 | 11.3K | +129% | $0 | |
| M | 2022-01-04 | 2022-01-03 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | S - Sale | $64.75 | -4,050 | 7,110 | -36% | -$262.2K |
| M | 2021-09-14 | 2021-09-13 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Dir | S - Sale | $63.76 | -5,000 | 9,000 | -36% | -$318.8K |
Purchase Sale Sale after option exercise All abbreviations